NJ-ADARE-PHARMACEUTICALS
Adare Pharmaceuticals, Inc. announced that Dr. Peter Richardson has joined the Company as Vice President, Research & Development and Chief Medical Officer. Dr. Richardson will be responsible for leading our Research and Development efforts worldwide and for the successful development of the Company’s pipeline.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161107006242/en/
“We are delighted to have Peter join the Adare team. His extensive experience in the successful development and approval of specialized pharmaceutical products and medical devices globally will be key to our organization, as we accelerate our development plans and implement our growth strategy,” said John Fraher, President and CEO of Adare Pharmaceuticals.
Dr. Richardson brings 30 years of medical practice, research and development experience in the pharmaceutical and medical device industry. Dr. Richardson has developed centers of excellence which enable product pipelines encompassing small molecules, biologics, novel formulations and medical devices. During his industry career he has managed programs leading to the submission and review of NDAs, sNDAs, BLAs and Marketing Authorization Applications in the US, Europe and Japan for over 20 marketed products.
He joins our team from Novartis Corporation where he was most recently the Chief Medical Officer for its eye care division Alcon. In this role he held multiple responsibilities including leading the company's clinical, regulatory and safety organizations globally and serving as its ad-interim head of research and development for its Pharmaceutical business.
Dr. Richardson is a physician with specialization in endocrinology, holding bachelors degrees of medical science (B.Med.Sci.), medicine and surgery (BM, BS) with honors from the University of Nottingham in the United Kingdom. He is a member of the Royal College of Physicians of the United Kingdom, MRCP (UK) and from whom he was also awarded a diploma in Pharmaceutical Medicine.
About Adare Pharmaceuticals
Adare is a global specialty pharmaceutical company inspired to improve the lives of patients whose treatment needs are not fully addressed by current medications. We use our unique combination of experience, proprietary capabilities, and resources to create meaningful products for them.
Our entrepreneurial and performance driven culture encourages us to take risks, identify promising ideas, and see those opportunities through to completion. Our collaborative spirit and dedication to developing strong partnerships provide Adare and our partners with significant advantages in competitive markets.
Adare is a high-growth company with a long history of success from concept through commercialization. Our ability to create differentiated drugs guides the identification and development of the novel products in our pipeline and our acquisition strategy.
For more information, visit www.adarepharma.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20161107006242/en/
Contact:
Adare Pharmaceuticals, Inc.
Carlotta Dillon, 908-938-4151
Carlotta.dillon@adarepharma.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Papa Johns Launches Its First-Ever Croissant Pizza, Giving Pizza Lovers Their Flakiest Bite Ever10.6.2025 17:38:00 CEST | Press release
Pizzas to be delivered in custom-made hot bag designed in collaboration with Colm Dillane – fashion disruptor, artist and founder of KidSuper - to a select number of lucky fans to keep Papa Johns is elevating the pizza experience with the global launch of its latest innovation: the all-new Croissant Pizza. The Croissant Pizza indulgently pairs the delicate, flaky texture of a buttery croissant with the bold flavors of Papa Johns pizza – bringing the brand’s Better Ingredients. Better Pizza.® promise to life through craft, quality and innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610316641/en/ Papa Johns Croissant Pizza takes the brand’s signature promise of Better Ingredients. Better Pizza. even further – delivering innovation, craftsmanship and quality through every crisp, buttery layer. A pizza this expertly crafted deserves to be delivered in cutting-edge artistic style. That’s why Papa Johns has teamed up
HCLTech Expands Partnership With The Standard to Accelerate AI-led Transformation and Deliver Digital-first Services at Scale10.6.2025 16:51:00 CEST | Press release
HCLTech, a leading global technology company, announced an expansion of its partnership with Standard Insurance Company (The Standard), a leading provider of financial protection products and services for employers and individuals. This expanded partnership with The Standard will deliver AI-driven infrastructure and application services to boost efficiency, support rapid growth and enhance customer experience. This collaboration will also accelerate The Standard’s shift to an IT products and services-based operating model, enabling greater agility, customer value and progress toward the company’s long-term digital transformation goals. HCLTech’s GenAI-led service transformation platform, AI Force, digital engineering and cloud services will support The Standard’s focus on exceptional customer service in the delivery of workplace benefits. This transformation will be further driven by a newly formed Joint Innovation Council and Digital Experience Office, reinforcing The Standard’s commi
Bermuda International Long Term Insurers and Reinsurers (BILTIR) Enlists Oliver Wyman to Analyse Systemic Risk in Region with New Report10.6.2025 16:45:00 CEST | Press release
Bermuda International Long Term Insurers and Reinsurers (BILTIR) today announced the release of a new report, titled Analysis of Systemic Risk in the Bermuda Long-Term Insurance Sector, published by Oliver Wyman through BILTIR’s commissioning. Using Oliver Wyman’s independent research and a variety of data sources, the report concludes that Bermuda’s long-term (re)insurance sector does not meaningfully contribute to global systemic risk. “Amid questions about systemic risk within the Bermuda (re)insurance sector, BILTIR engaged experts at Oliver Wyman to conduct an independent examination of the industry and regulatory environment within our jurisdiction,” said Suzanne Williams-Charles, CEO of BILTIR. “Bermuda’s system is in place to manage risk and protect policyholders, and this report verifies that Bermuda’s diligent regulatory framework is effectively limiting any potential for systemic risk.” The report evaluated three hypothetical scenarios frequently cited by regulators to quest
Info-Tech Research Group Names Laserfiche a Leader in Enterprise Content Management – Enterprise Report10.6.2025 16:00:00 CEST | Press release
Laserfiche has been named a Champion for the enterprise category in the Enterprise Content Management Emotional Footprint 2025 Report by Info-Tech Research Group. Laserfiche — the leading enterprise platform that helps organizations manage their most critical content and workflows — was recognized based on reviews provided by end users. Laserfiche was named a Champion for having great customer relationships and a product that delivers a strong return on investment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610817168/en/ Laserfiche Champions at Empower 2025 “We are excited to be recognized as a 2025 Emotional Footprint Champion,” said Thomas Phelps, CIO and SVP of corporate strategy at Laserfiche. “Out of 416 customers who completed Info-Tech surveys this year, 99% shared they plan to renew. “Our customers have recognized us not only for delivering innovative, high-impact solutions, but for building trust and providin
Hana RFID Appoints Sipi Savolainen as Sales Director Europe & Middle East to Accelerate Regional Growth10.6.2025 16:00:00 CEST | Press release
Appointment Signals Commitment to Expanding Hana’s straightforward, partner-oriented approach in RFID Inlay design and manufacturing. Hana Technologies, Inc. (Hana RFID), a global leader in RAIN RFID inlay and embeddable tag design and manufacturing, announces the appointment of Sipi Savolainen as the company’s new Sales Director for Europe & Middle East. Savolainen’s primary objective will be to drive business growth in retail and beyond, reinforcing Hana’s reputation as a reliable partner towards RFID industry partners, including label converters, service bureaus, and system integrators. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610582555/en/ Sipi Savolainen joins Hana RFID as its new Sales Director Europe & Middle East to Accelerate Regional Growth and improve customer satisfaction. With over 20 years of industry experience, Savolainen brings a wealth of expertise and a strong record of guiding early adopters and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom